As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted ...

In youth newly diagnosed with type 2 diabetes, GLP-1–based therapies, including semaglutide and tirzepatide, achieved similar ...

Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP ...

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

The White Houes may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...

The rise of GLP-1 weight loss drugs has been a game-changer for the grocery sector, and the dairy segment appears ...

NVO's new U.S. pricing deal for Ozempic and Wegovy expands access but adds uncertainty to its growth and profit outlook.

Foodsmart, the leading telenutrition and foodcare provider nationwide, is expanding access to its GLP-1 Companion Care program after validating savings of $2,000 per GLP-1 patient annually versus ...

Working alongside primary care physicians, hospitalists, and other clinicians, pharmacists help ensure more seamless handoff ...

GLP-1 drugs manufactured by Eli Lily and Novo Nordisk will cost as much as $350 per month for eligible patients.